임신 중 methyl estradiolpropanoate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

methyl estradiolpropanoate은 임신 중 안전한가요?

Topical Methyl Estradiolpropanoate (MEP) has been shown in human studies to activate estrogenic effects in skin (clinical trials of Emepelle products), indicating estrogen receptor activity and potential for systemic exposure; estradiol and active estrogens have known reproductive/teratogenic risks in pregnancy, so this derivative is a suspected reproductive hazard. Sources: clinical studies showing topical efficacy and product ingredient lists. (PubMed clinical trial; product ingredient pages).

methyl estradiolpropanoate은 모유 수유 중 안전한가요?

Because MEP is an estrogen derivative with demonstrated topical activity, it is reasonably suspected to produce systemic estrogenic exposure after dermal application; estradiol transfers into breast milk, so a conservative classification is 'suspected' hazard for breastfeeding unless data showing negligible systemic absorption are provided. No regulatory harmonised CMR classification or EU ban/restriction was found to override this assessment.

methyl estradiolpropanoate은 아기 피부에 안전한가요?

Hazard and mechanism mirror adults (suspected estrogenic reproductive hazard / demonstrated estrogen receptor activity). Exposure score is increased for infant skin because infant skin has higher absorption (immature barrier, higher surface‑area‑to‑weight) and the ingredient has measurable topical activity in adults, so exposure to a baby (0–3 yr) would be higher.

VeriMom은 methyl estradiolpropanoate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 methyl estradiolpropanoate을 33/100 (높은 위험)로 평가합니다.

임신 중 methyl estradiolpropanoate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.